Molecular Identification of a Malaria Merozoite Surface Sheddase by Harris, Philippa K et al.
Molecular Identification of a Malaria
Merozoite Surface Sheddase
Philippa K. Harris
1[, Sharon Yeoh
1[, Anton R. Dluzewski
2,3, Rebecca A. O’Donnell
1, Chrislaine Withers-Martinez
1,
Fiona Hackett
1, Lawrence H. Bannister
3, Graham H. Mitchell
2, Michael J. Blackman
1*
1 Division of Parasitology, National Institute for Medical Research, London, United Kingdom, 2 Department of Immunobiology, Guy’s, King’s and St. Thomas’ Hospitals School
of Medicine, London, United Kingdom, 3 Wolfson Centre, Guy’s, King’s and St. Thomas’ Hospitals School of Biomedical and Life Sciences, London, United Kingdom
Proteolytic shedding of surface proteins during invasion by apicomplexan parasites is a widespread phenomenon,
thought to represent a mechanism by which the parasites disengage adhesin-receptor complexes in order to gain entry
into their host cell. Erythrocyte invasion by merozoites of the malaria parasite Plasmodium falciparum requires the
shedding of ectodomain components of two essential surface proteins, called MSP1 and AMA1. Both are released by
the same merozoite surface ‘‘sheddase,’’ but the molecular identity and mode of action of this protease is unknown.
Here we identify it as PfSUB2, an integral membrane subtilisin-like protease (subtilase). We show that PfSUB2 is stored
in apical secretory organelles called micronemes. Upon merozoite release it is secreted onto the parasite surface and
translocates to its posterior pole in an actin-dependent manner, a trafficking pattern predicted of the sheddase.
Subtilase propeptides are usually selective inhibitors of their cognate protease, and the PfSUB2 propeptide is no
exception; we show that recombinant PfSUB2 propeptide binds specifically to mature parasite-derived PfSUB2 and is a
potent, selective inhibitor of MSP1 and AMA1 shedding, directly establishing PfSUB2 as the sheddase. PfSUB2 is a new
potential target for drugs designed to prevent erythrocyte invasion by the malaria parasite.
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Introduction
Malaria is a devastating global health problem, responsible
for up to 3 million deaths annually [1]. The disease results
from cyclical replication within erythrocytes of protozoan
parasites of the genus Plasmodium. The parasite divides
asexually within its host cell to produce a number of progeny
merozoites. Upon eventual rupture of the schizont, these are
released to rapidly invade fresh red cells and perpetuate the
cycle. Like all apicomplexan parasites, the Plasmodium
merozoite enters its host cell by an active invasion process
that is mediated by adhesive receptor–ligand interactions and
driven by an actinomyosin motor [2]. Light and electron
microscopic studies have shown that initial attachment to the
host erythrocyte is followed by reorientation of the merozoite
such that its apical end contacts the cell surface. This results
in the formation of an irreversible zone of contact, or tight
junction, between the apical prominence and the host cell
surface. The host cell membrane then invaginates, forming a
parasitophorous vacuole (PV) into which the parasite is
propelled; in the process, the junction sweeps around the
periphery of the parasite with concomitant ‘‘shaving’’ of
bristle-like structures from the parasite surface [3,4], even-
tually sealing behind the intracellular parasite. The initial
low-afﬁnity binding appears to be mediated by a large,
glycosylphosphatidyl inositol (GPI)-anchored protein com-
plex which is uniformly distributed around the parasite
surface and is composed of fragments of merozoite surface
protein-1 (MSP1) plus associated partner proteins [5–7].
Many subsequent interactions in the invasion pathway are
mediated by proteins released from micronemes, secretory
vesicles at the apical end of the merozoite [8]. One of these
proteins, apical membrane antigen-1 (AMA1), is a type I
integral membrane protein that is secreted onto the
merozoite surface just prior to interaction with the host cell
and may play a role in reorientation, junction formation, or
government of the release of a second set of apical organelles
called rhoptries [9–11]. Both MSP1 and AMA1 play essential
roles in the blood-stage cycle of the malaria parasite [12,13].
During invasion both AMA1 and the MSP1 complex are
quantitatively shed from the parasite surface, in each case as a
result of a single proteolytic cleavage at a juxtamembrane
site. Shedding of MSP1 results from cleavage just distal to a
tandem EGF (epidermal growth factor)-like domain called
MSP119 at its C-terminus [14]. MSP119 remains bound to the
parasite surface via its GPI anchor and is the only part of the
MSP1 complex to be carried into the host cell. AMA1 is
cleaved precisely 29 residues away from the transmembrane
domain (TMD), releasing the bulk of the ectodomain and
resulting in just the juxtamembrane ‘‘stub’’ being carried into
the host cell with its cognate TMD and cytoplasmic domain
[15–17]. Shedding of these proteins is required for productive
invasion [7,18,19], and may be important to release adhesive
interactions between the parasite and host cell surface in
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The MSP1 complex is an abundant merozoite component,
and together with AMA1 likely corresponds to the surface
structures shed adjacent to the moving junction. Importantly,
shedding of both AMA1 and the MSP1 complex can occur
even in the absence of invasion, and a simple assay based on
the use of isolated merozoites has shown that both proteins
are shed by the same parasite-derived, membrane-bound,
calcium-dependent serine protease, called merozoite surface
sheddase, or MESH [16,20]. MESH is active against its
physiological substrates only when in the same membrane
[21]. Its molecular identiﬁcation has proved elusive, but the
accumulated microscopic and biochemical evidence suggests
that at invasion it must distribute across the surface of the
parasite, probably localising at the moving junction [7,20]. We
and others have previously identiﬁed a large, membrane-
bound subtilisin-like serine protease called SUB2 that is
expressed in the late stages of intraerythrocytic development
and accumulates within the apical domain of the merozoite
[22,23]. The enzyme has not been expressed in a recombinant,
enzymatically active form, but SUB2 is conserved throughout
Plasmodium, and attempts to disrupt both the Plasmodium
falciparum gene (pfsub2) and that of the rodent malaria P.
berghei have been unsuccessful [24,25], indicating an essential
function within the blood-stage cycle. Here we present the
ﬁrst experimental evidence that PfSUB2 is MESH, and show
that it has the remarkable capacity to translocate across the
merozoite surface exactly as predicted.
Results
Epitope Tagging of PfSUB2 by Targeted Homologous
Recombination
PfSUB2 is a poorly abundant parasite protein, hindering
our earlier attempts at precise sub-cellular localization of the
mature protein. To overcome this obstacle, we set out to
modify the endogenous pfsub2 gene by fusing it to a sequence
encoding three consecutive haemagglutinin (HA) epitope tags
using targeted homologous recombination. Parasites trans-
fected with construct pHH1-T996HA3 and the control
plasmid pHH1-T996w (Figure 1A) were cultured in the
presence of the antifolate WR99210 followed by rounds of
drug cycling to remove parasites harbouring free episomes
(which are rapidly lost in the absence of drug pressure). The
resulting parasite lines, called PfSUB2HA and PfSUB2w, were
cloned by limiting dilution and maintained in the presence of
WR99210. Southern blot analysis (Figure 1B) showed that all
transgenic clones contained more than one copy of the
targeting plasmid integrated into the pfsub2 locus, as is
common in single-crossover homologous recombination in P.
falciparum as a result of the plasmids being maintained as
concatamers (e.g., [13]). Note that despite this, only one copy
of the modiﬁed gene is expected to be functional, because all
downstream copies contain either the targeting fragment
only or a promoterless, truncated remnant of the endogenous
locus lacking the epitope tag. In over 6 mo of continuous
culture, none of the clones exhibited any growth defect
compared to the parental D10 clone (not shown), indicating
that neither the addition of the HA tags to the C-terminus of
PfSUB2 nor replacement of the pfsub2 39 UTR with the
heterologous P. berghei sequence was detrimental to parasite
replication.
Analysis of the transgenic clones by Western blot using two
different HA-speciﬁc monoclonal antibodies (mAbs), 12CA5
and 3F10, conﬁrmed the in-frame fusion of the epitope tag to
PfSUB2. Pulse-chase studies have shown that PfSUB2 matu-
ration involves two post-translational processing steps in
which the approximately 150-kDa primary translation prod-
uct (called PfSUB2P) is converted ﬁrst to a 75-kDa inter-
mediate form (PfSUB2I) and ﬁnally to a 72-kDa terminal
intracellular form (PfSUB2T) [23,25]. All were detected in
schizont extracts probed with the anti-HA mAbs (Figure 1C;
the closely spaced PfSUB2I/PfSUB2T doublet is not easily
discernible here, but see below), consistent with our earlier
evidence that maturation of PfSUB2 involves truncation from
the N-terminus of the protein. An additional anti-HA
reactive species of 55 kDa, also often evident on Western
blots, has previously been observed as a minor component in
pulse-chase experiments, and is likely a non-speciﬁc degra-
dation product of PfSUB2.
PfSUB2 Is a Microneme Protein
To establish the sub-cellular location of PfSUB2, parasites
were then analysed by indirect immunoﬂuorescence (IFA)
using both of the anti-HA mAbs. Neither mAb showed any
reactivity with any stages of the PfSUB2w line or clones
thereof, or with the parental D10 clone (not shown). In
contrast, both mAbs produced a strong punctate pattern in
mature schizonts of both the uncloned PfSUB2HA line (not
shown) and its clones. To examine this localisation in detail,
dual labelling was performed using mAbs speciﬁc for a
plasma membrane marker (MSP1), two different rhoptry
markers (RhopH2 and RAP2; data not shown for RAP2), and a
microneme protein (AMA1). The results were clear (Figure
2A); the anti-HA signal was quite different from that of MSP1,
it was adjacent to but distinct from that of the rhoptry-
speciﬁc signals, but it co-localised completely with that of
AMA1, indicating that in mature schizonts, PfSUB2 accumu-
lates in micronemes.
These ﬁndings were conﬁrmed by immuno-electron
microscopy (IEM) using the anti-HA mAb 3F10, which
showed light but consistent labelling of typical elongated
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Synopsis
Malaria causes immense suffering and loss of life across the globe. In
the face of growing resistance to available drugs and no licensed
vaccine, new approaches are urgently required to tackle its control.
Fundamental to these is an improved understanding of the basic
biology of the malaria parasite. The parasite invades and replicates
within red blood cells. During invasion a number of important
proteins need to be shed from the parasite surface, probably in
order to disengage the adhesive interactions that enable initial
binding. Shedding of these surface proteins is achieved by a parasite
enzyme called a protease, and compounds or antibodies that block
the action of this protease prevent invasion, killing the parasite. Here
the authors identify this protease as PfSUB2, a large, membrane-
bound member of the subtilisin-like protease superfamily. They find
that PfSUB2 is secreted from apical organelles called micronemes at
the point of invasion to migrate rearwards over the surface of the
parasite, and that a protein designed to be a specific inhibitor of
PfSUB2 potently prevents shedding of parasite surface proteins. This
work sets the scene for the development of inhibitors of PfSUB2 as a
new generation of antimalarial drugs.micronemes within late-stage schizonts (Figure 2B), similar
to that of AMA1 (Figure 2C). No labelling with mAb 3F10
was observed in less-mature schizont stages lacking micro-
nemes, or apically in free merozoites, and labelling was also
absent from wild-type schizont controls (not shown). There
was no evidence of any dense granule labelling with the
anti-HA antibody.
PfSUB2 Is Secreted to Translocate across the Surface of
Free Merozoites
To follow the fate of PfSUB2 upon merozoite release,
naturally released merozoites were next examined by IFA as
described above. As with intracellular parasites in mature
schizonts, all merozoites exhibited an intense, punctate anti-
HA signal. Unexpectedly, however, in the great majority of
Figure 1. Epitope Tagging of PfSUB2
(A) Schematic depiction of integration plasmids pHH1-T996HA3 and pHH1-T996w, and single-crossover homologous recombination events (for clarity
shown only for pHH1-T996HA3). Integration reconstitutes a full-length pfsub2 gene either with or without a triple HA tag at the 39 end. Correct
transcription termination and polyadenylation of this gene is regulated by the presence of the P. berghei dihydrofolate reductase 39 UTR (PbDT 39 UTR).
hdhfr, human dihydrofolate reductase, conferring resistance to the antifolate WR99210. S, indicates the ScaI sites. P indicates the position and size of the
probe used for Southern analysis.
(B) Southern blots of ScaI-digested input plasmid pHH1-T996HA3 or genomic DNA from PfSUB2w clones F7 and D8, PfSUB2HA clones 10E and 2D, and
wild-type D10 parasites. The position of the genomic 3.4-kb fragment derived from the wild-type (wt) pfsub2 locus is arrowed. Its disappearance from all
the transgenic clones indicates disruption of this locus, whilst the appearance of the additional species at 5.8 kb and 4.4 kb indicates integration as
predicted. The fragments seen at the position of full-length input plasmid derive from integration of more than one copy of the entire plasmid, as
described in the text.
(C) Western blot of transgenic clones using anti-HA mAb 3F10 (identical results were obtained using anti-HA mAb 12CA5; not shown) or anti-RAP2 mAb
H5, used as a loading control. Identities of the authentic PfSUB2 species are indicated, and the 55-kDa PfSUB2 degradation product (the abundance of
which varied widely between experiments, being most prominent in non-ionic detergent extracts incubated for prolonged periods) is marked with an
asterisk. Note that the predicted molecular mass of an HA-tagged minimal PfSUB2 catalytic domain (extending from the catalytic Asp755 to the end of
the C-terminal tag) is approximately 70 kDa. Molecular masses are in kDa.
DOI: 10.1371/journal.ppat.0010029.g001
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PfSUB2 Is a Merozoite Surface Sheddasecases ( 70% of free merozoites), it comprised a single tight
focus of ﬂuorescence that clearly localised to the opposite
pole of the merozoite to that recognised by the anti-rhoptry
mAbs. This posterior localisation was also found in the free
merozoite by IEM, labelling being present just interior to the
cell surface, consistent with antibodies binding to the epitope
tag at the extreme C-terminus of the PfSUB2 cytoplasmic
domain (Figure 2D and 2E; Figure 3A, top row). There are no
known organelles situated at the posterior of the merozoite, so
this suggested that, just after schizont rupture, PfSUB2 is
secreted from the micronemes onto the merozoite surface and
redistributed rearwards to accumulate at its posterior end. In
a portion of cases (;10%), the anti-HA IFA signal presented
as two separate foci that lay lateral to the anterior–posterior
axis of the merozoite, suggesting the presence of a mid-bodied
ring of ﬂuorescence encircling the parasite at right angles to
this axis and perhaps representing PfSUB2 en route to the
posterior (Figure 3A, middle row). Only in less than 20% of
cases did the anti-HA IFA signal remain adjacent to the
rhoptries as reproducibly observed in intact schizonts. In
contrast, the anti-AMA1 IFA signal in free merozoites took the
form of a uniform circumferential pattern (Figure 3A, bottom
row) as observed previously (e.g., [16]). In no case did the anti-
AMA1 IFA signal concentrate at the posterior pole of the
parasite as seen for the anti-HA signal. Several apicomplexan
microneme proteins translocate onto the parasite surface
upon release from the host cell. The best-studied example, the
Toxoplasma adhesin TgMIC2/M2AP, is secreted spontaneously
at low basal levels and capped to the posterior pole of the free
tachyzoite. As the parasite invades a host cell, secretion is
markedly up-regulated and driven rapidly to completion [26].
Our observations suggest that PfSUB2 behaves in a somewhat
similar manner, although complete translocation of PfSUB2
can apparently occur even in the absence of host cell invasion.
These ﬁndings document the ﬁrst demonstration of capping
of a Plasmodium merozoite surface protein. Importantly, the
trafﬁcking pattern observed indicates that PfSUB2 has the
capacity to track along the merozoite surface, a characteristic
predicted of a membrane-bound protease involved in shed-
ding of merozoite surface proteins.
Translocation of PfSUB2 Is Actin Dependent
The unique form of substrate-dependent gliding motility
exhibited by many Apicomplexa is mediated by interactions
between the cytoplasmic domains of transmembrane adhe-
sins, such as TgMIC2/M2AP or its Plasmodium sporozoite
homologue, TRAP, and a subplasmalemmal actinomyosin
motor [2]. Compounds that interfere with this motor block
motility and invasion, and prevent capping of several micro-
nemal adhesins, though not their secretion per se (e.g.,
[27,28]). To test the possibility that this or a similar actin-
dependent system might drive PfSUB2 translocation, we
investigated the effects of latrunculin A and cytochalasin D,
two inhibitors of actin polymerisation with distinct mecha-
nisms of action. As shown in Figure 3B, 5 lM latrunculin A
clearly inhibited posterior accumulation of PfSUB2 on
released merozoites, with approximately 90% of free para-
sites exhibiting instead a diffuse distribution of the anti-HA
signal at or around the apical region of the merozoite. This
result indicates that rearward translocation of PfSUB2 is
actin dependent. In contrast, cytochalasin D had no effect on
PfSUB2 capping, even at concentrations as high as 4 lM
Figure 2. PfSUB2 Is a Microneme Protein
(A) IFA images of schizonts of PfSUB2HA clone 2D dual-labelled with
mAbs X509 (anti-MSP1), 61.3 (anti-RhopH2), or 4G2 (anti-AMA1), plus in
each case mAb 3F10 (anti-HA) The anti-HA signal co-localised only with
the anti-AMA1 signal. Identical results were obtained with the uncloned
transgenic PfSUB2HA line, and/or when anti-RAP2 mAb H5 was used as
the rhoptry marker instead of mAb 61.3 (not shown). Parasite nuclei are
stained throughout with DAPI (blue). Scale bar represents 2 lm.
(B and C) Electron micrographs showing immuno-gold labelling of
micronemes within late-stage schizonts of PfSUB2HA clone 2D using: (B)
anti-HA mAb 3F10, detecting epitope-tagged PfSUB2; and (C) a
polyclonal antibody specific for PfAMA1. The inset in (B) shows another
example of micronemal staining with mAb 3F10 from another schizont.
Rh, rhoptry.
(D and E) Posterior labelling of with anti-HA mAb 3F10 in a free
merozoite of PfSUB2HA clone 2D. Arrows indicate immuno-gold label-
ling. Rh, rhoptry.
DOI: 10.1371/journal.ppat.0010029.g002
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PfSUB2 Is a Merozoite Surface Sheddase(Figure 3B). This was surprising given the known inhibitory
effect of cytochalasins on invasion by the malaria merozoite
[29], but identical results were obtained in three independent
experiments using two different batches of the drug.
PfSUB2 Remains on the Plasma Membrane of Invading
Parasites
Probing newly invaded ring-stage parasites from highly
synchronised cultures of the PfSUB2HA clones with mAb
3F10 produced a ‘‘ring-shaped’’ signal that co-localised with
that of a mAb speciﬁc for MSP119, the fragment of MSP1 that
remains on the parasite surface after invasion (Figure 3C). By
4–6 h post invasion, the anti-HA IFA signal was no longer
detectable, only to appear again in a punctate form in the late
stages of schizont maturation (not shown). PfSUB2 expression
peaks in the latter stages of intraerythrocytic maturation
[22,30,31], so the signal observed in early rings must derive
from PfSUB2 carried into the cell on the merozoite surface.
Collectively, the developmental proﬁle of PfSUB2 expression
and sub-cellular trafﬁcking, its ability to mobilise onto and
across the merozoite surface, and its presence at the plasma
membrane of newly invaded ring stages are entirely con-
sistent with an involvement in MESH activity.
Recombinant PfSUB2 Propeptide Is Folded and Binds
Specifically to Mature Parasite-Derived PfSUB2
Subtilases are synthesised as zymogens that comprise
minimally a secretory signal peptide, a propeptide, and a
catalytic domain. The propeptide acts as an intramolecular
chaperone, being essential for folding of the catalytic domain.
Subtilase propeptides are also highly potent, selective
inhibitors of their cognate proteases (e.g., [32–34]), a property
that is probably important in regulating subtilase activation
during secretion. Prompted by the ﬁnding that PfSUB2 is
actively distributed across the free merozoite surface, we
investigated whether its propeptide could interfere with
MESH activity.
By analogy with processing of PfSUB1 [33] and other
subtilases, conversion of PfSUB2P to the 75-kDa PfSUB2I
form likely represents autocatalytic cleavage of the propep-
tide. From the mass of this species we calculated that
propeptide cleavage occurs between residues Tyr680 and
Lys720 of the PfSUB2 sequence. We therefore expressed in
Escherichia coli a series of propeptide constructs of varying
size, in each case extending from Asn22 (the predicted N-
terminus after signal peptide removal) and terminating at
different residues within the above range. Constructs were
fused to a short N-terminal peptide containing a His6 tag and
an S-tag (Figure 4A), an approach previously used successfully
to express and characterise the PfSUB1 propeptide [33]. The
protein comprising Asn22-Leu687 (called PfSUB2PD) was
expressed at the highest levels, and so further work focused
exclusively on this. Preliminary puriﬁcation trials showed
PfSUB2PD to be susceptible to degradation, so to optimise
yields, much of the puriﬁcation was routinely performed in
the presence of 8 M urea (Figure 4B). Puriﬁed PfSUB2PD was
refolded into aqueous buffer and its identity conﬁrmed by
Western blot and mass spectrometry (not shown).
Circular dichroism (CD) analysis revealed that PfSUB2PD
possesses substantial secondary structure (Figure 4C). Sub-
tilisin propeptides broadly divide into two groups according
to their folding capacity; whereas some are unfolded when
Figure 3. PfSUB2 Redistributes to the Free Merozoite Posterior in an
Actin-Dependent Manner
(A)IFAimagesoffreemerozoitesofPfSUB2HAclone2Ddual-labelledwith
mAb 61.3 (anti-RhopH2) and either mAb 3F10 (anti-HA) or 4G2 (anti-
AMA1). The anti-HA signal formed either a single punctate signal at the
extremeposteriorofthemerozoite(top),ortwinfocilateraltoitsanterior–
posterior axis (middle). Identical results were obtained using PfSUB2HA
clone 10E, or using anti-RAP2 mAb H5 as the rhoptry marker (not shown).
(B) Latrunculin inhibits rearward translocation of PfSUB2. Merozoites of
PfSUB2HA clone 2D released into medium containing 1% (v/v) DMSO
only (solvent control), or 5 lM latrunculin A (Latrunc), or 4 lM
cytochalasin D (Cyt D), probed as above with mAb 61.3 (anti-RhopH2)
and mAb 3F10 (anti-HA). Note that neither compound had any effect on
the efficiency of schizont rupture and merozoite release, nor on AMA1
relocalisation, but both blocked erythrocyte invasion by more than 95%
at the concentrations used (not shown).
(C) PfSUB2 remains at the plasma membrane of the newly invaded
parasite. Ring stages of PfSUB2HA clone 2D ( 2 h post-invasion) probed
with anti-MSP1 mAb 1E1 and anti-HA mAb 3F10. Parasite nuclei are
stained throughout with DAPI (blue). Scale bar represents 2 lm.
DOI: 10.1371/journal.ppat.0010029.g003
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PfSUB1 propeptide—adopt signiﬁcant secondary structure in
isolation [33,34,36]. The CD data indicate that the propeptide
of PfSUB2 falls into this second class. Subtilase propeptides
vary considerably in size and exhibit little sequence homology
across evolution, but structural determination of folded
propeptides from bacteria [37–39] and mammals [36] have
shown that they share a core structure with a simple ab fold.
The observed ab content of PfSUB2PD is consistent with such
a structure.
To seek direct evidence that PfSUB2PD was capable of
binding to its cognate protease, puriﬁed PfSUB2PD was
incubated with detergent extracts of PfSUB2HA clone 2D
then recovered using S-protein agarose beads. Puriﬁed
PfSUB1 propeptide (PfSUB1PD) was used as a control in
these experiments. Figure 5 shows that of the four PfSUB2-
derived species present in the detergent extracts, only
PfSUB2I and PfSUB2T—those forms predicted to lack the
propeptide—were signiﬁcantly bound by PfSUB2PD. Only
traces of all four proteins were bound by PfSUB1PD.
Reprobing these Western blots with high-titre polyclonal
antibodies speciﬁc for AMA1, MSP1, or RAP2, all abundant
schizont proteins, revealed no non-speciﬁc binding of any of
these proteins to PfSUB2PD (not shown). These results
demonstrate that PfSUB2PD can form a speciﬁc molecular
complex with the mature forms of PfSUB2.
The PfSUB2 Propeptide Is a Potent and Selective Inhibitor
of MESH Activity
Puriﬁed PfSUB2PD was then tested for its effect on MESH
activity in isolated intact merozoites, taking advantage of an
assay previously used extensively to characterise the inhibitor
sensitivity of the sheddase. Figure 6A shows that PfSUB2PD
potently inhibited shedding of both AMA1 and MSP1 in a
dose-dependent manner, with a calculated IC50 (inhibitory
concentration 50%) of approximately 300 nM, whilst
PfSUB1PD had no detectable effect. Identical levels of
inhibition were obtained with slightly less-pure preparations
of PfSUB2PD, similar to those in lane 2 in Figure 4B, that had
been puriﬁed in the absence of urea and had not been
subjected to reversed phase–high performance liquid chro-
matography (RP-HPLC) (not shown).
To assess the selectivity of the inhibition mediated by
PfSUB2PD, we examined its effect on the activity of
recombinant PfSUB1 (Figure 6B). PfSUB2PD had no effect
at the highest concentrations tested (1.2 lM), whereas
PfSUB1PD rapidly abolished protease activity as reported
previously [33]. To further assess whether PfSUB2PD had any
capacity to act as a general serine protease inhibitor, we
examined its activity against a range of other serine proteases
using standard colorimetric or ﬂuorescence-based assays. At
concentrations equivalent to between 12- and 300-fold molar
excess over protease, PfSUB2PD had no effect on the activity
of chymotrypsin, trypsin, and elastase, though it exhibited
just-detectable inhibitory activity against subtilisin Carlsberg
and measurable activity against subtilisin BPN9 with a
calculated Ki value of 1.2 lM (data not shown). Similar
inhibition of heterologous subtilases by subtilase propeptides
has been noted previously (e.g., [32,34]). Taken together with
the binding data above, these results provide compelling
evidence that the inhibition of AMA1 and MSP1 shedding
mediated by recombinant PfSUB2PD is a direct result of it
Figure 4. Recombinant PfSUB2 Propeptide Is Soluble and Structured
(A) Schematic of the PfSUB2PD construct. Full-length PfSUB2 is
represented with the secretory signal peptide and TMD indicated in
black and the catalytic and cytoplasmic domains in shades of grey.
PfSUB2PD possesses a cleavable 46-residue N-terminal fusion peptide
containing a His6 and an S-tag, shown in dark grey.
(B) Coomassie-stained SDS PAGE gel showing stages in the purification
of PfSUB2PD. Lane 1, Ni-NTA agarose eluate enriched in PfSUB2PD; lane
2, peak fraction from Superdex 200 gel filtration of previous lane in 8 M
urea; lane 3, peak fraction from the final RP-HPLC step; lane 4, purified
PfSUB1 propeptide (PfSUB1PD). Lane M contains molecular mass
markers, the sizes of which are indicated.
(C) Far-ultraviolet CD spectrum of purified refolded PfSUB2PD. Deconvo-
lution of the spectrum obtained calculated secondary structure values of
24% a-helix, 23% b-sheet, 21% reverse turn, and 32% random coil.
DOI: 10.1371/journal.ppat.0010029.g004
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the merozoite surface.
Discussion
Proteolytic shedding of surface proteins during invasion by
apicomplexan parasites is thought to be a strategy by which
adhesion–receptor complexes are removed as the parasite
enters its host cell. Shedding of MSP1 by cleavage just
upstream of its C-terminal EGF-like region occurs in all
species of Plasmodium examined, and new interest in the
protease responsible was sparked by the revelation that the
same protease also mediates release of another essential
surface protein, AMA1. Here we have identiﬁed this protease
as PfSUB2, an integral membrane merozoite subtilase.
PfSUB2 is a very minor parasite component, and in an
earlier study [23], we were insufﬁciently conﬁdent in our
antibody localisation data to assign it to a speciﬁc sub-cellular
location. By epitope tagging the endogenous pfsub2 gene and
using a range of mAbs to study its expression proﬁle
compared to other well-deﬁned markers, we have now
deﬁnitively localised PfSUB2 to micronemes. This differs
from the conclusions of Barale et al. (1999) [22] who used
polyclonal antibodies to obtain evidence suggesting that
PfSUB2 localizes to a different set of organelles called dense
granules. However, cross-reactivity of polyclonal antibodies
combined with the small dimensions of the malaria merozoite
can render localization of sub-cellular components partic-
ularly challenging, and merozoite proteins have been
previously mis-localised (e.g., [40]). A possible alternative
explanation for the discrepancy between these results is that
epitope tagging of PfSUB2 resulted in its mistargeting. This
phenomenon has previously been observed in Apicomplexa,
but seems most unlikely in this case; given the evidence that
PfSUB2 is an essential gene product, a defect in sorting would
likely have phenotypic consequences. Our transgenic lines
and clones displayed normal growth and morphology.
Importantly, moreover, our conclusions are lent credence
by the ﬁnding that PfSUB2 is secreted onto the parasite
surface prior to or at invasion, an activity typical of
microneme proteins. Dense granule proteins, in contrast,
are discharged predominantly following invasion [41].
Collectively, our ﬁndings support the following model.
PfSUB2 undergoes maturation by post-translational proteo-
lytic processing that is initiated by propeptide cleavage and
results in the formation of a membrane-bound protease. By
analogy with PfSUB1 maturation [25], both PfSUB2I and
PfSUB2T are likely to be enzymatically active, but it is
probably the PfSUB2T form that accumulates in micronemes
where it is stored until schizont rupture. At merozoite release
PfSUB2 is secreted onto the parasite surface where it engages
with an actin-based motor. This could occur through its
cytoplasmic domain or through ectoplasmic interactions with
other micronemal proteins that are themselves connected to
the motor. PfSUB2 is then shuttled towards the posterior pole
of the merozoite, in the process encountering and cleaving the
MSP1 complex and AMA1 from the surface of the parasite.
Our present results show that this capping process can occur
efﬁciently in the absence of invasion, satisfactorily explaining
the limited shedding of MSP1 and AMA1 seen in preparations
of free merozoites. However, our observations may not
accurately reﬂect the dynamics of PfSUB2 translocation at
invasion. The invasive half-life of P. falciparum merozoites is
extremely short, and shedding of MSP1 is known to go to
completion during the brief (;30 s) time course of eryth-
rocyte invasion [7]. We therefore propose that—similar to
TgMIC2/M2AP—capping of PfSUB2 on the invading merozoite
likely occurs predominantly concomitant with invasion, the
protease perhaps concentrating at the moving junction. IEM
studies of merozoites ‘‘captured’’ in the process of invasion
will be required to test this postulate. Unfortunately this is a
highly ambitious goal in P. falciparum in which, as a result of
the short invasive half-life of merozoites, no surface protein
has ever been localised by this technique on the invading
parasite. The issue would be best addressed in the simian
malaria model P. knowlesi, free merozoites of which are
relatively long lived. This will be a major focus of future work.
An additional prediction of our model is that PfSUB2 may
not be substantially exposed at the surface of the invasive
merozoite prior to the point of junction formation. In
support of this, we have found that addition of puriﬁed
PfSUB2PD to parasite cultures has no effect on invasion (P.
Harris, unpublished data). In an analogous example, anti-
bodies against sporozoite TRAP or TgMIC2 have no effect on
invasion, because these adhesins are not displayed at high
levels on the parasite surface until the point of invasion, and
only those molecules inhabiting the moving junction are
functional during invasion [42] (V. Carruthers, personal
communication). Nonetheless, we expect that it should be
possible to target PfSUB2 with appropriately selective low-
molecular weight, membrane-permeable compounds.
Capping of PfSUB2 to the merozoite posterior could be
prevented by latrunculin A but not by cytochalasin D, a
Figure 5. PfSUB2PD Binds to Mature Parasite PfSUB2
Sodium deoxycholate extracts of PfSUB2HA clone 2D were incubated
with either purified PfSUB1PD or PfSUB2PD, then the propeptides were
recovered with S-protein agarose and subjected to SDS PAGE and
Western blot using anti-HA mAb 3F10. The PfSUB2I and PfSUB2T species
bound by PfSUB2PD are indicated. Molecular mass markers are in kDa.
DOI: 10.1371/journal.ppat.0010029.g005
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on invasion by the malaria merozoite and the fact that both
compounds prevent invasion at the concentrations used here.
Both drugs induce rapid disruption of the actin cytoskeleton
in mammalian cells, but through distinct mechanisms;
whereas cytochalasin D binds to ﬁlamentous actin, inhibiting
polymerization at both barbed and pointed ends [43],
latrunculin binds to and sequesters actin monomers, pre-
venting their de novo polymerization [44,45]. One conse-
quence of this is that cytochalasin D does not induce net
depolymerization of actin, whereas latrunculin does [46,47],
and there are now numerous examples of cellular actin-based
processes that exhibit differential sensitivity to these drugs
(e.g., [47,48]). Only a single actin gene is expressed in P.
falciparum merozoites, and a recent study has shown that
ﬁlaments formed by this actin are unusually short [49]. One
explanation for the discrepancy between the effects observed
with the two actin antagonists used in our experiments is that
the degree of actin polymerisation required to provide the
traction for invasion may be much greater that than required
to translocate the bulk of secreted PfSUB2 the short distance
(;1.2 lm) from the apical region of the merozoite to its
posterior. This could explain why invasion is more sensitive
than capping of PfSUB2 to perturbation by cytochalasin D.
The motility of apicomplexan zoites is stringently regu-
lated, primarily by control of actin polymerization [50], and
in highly motile apicomplexan zoites such as the Toxoplasma
tachyzoite, motility ceases abruptly after invasion, implying
rapid disassembly of the actinomyosin motor. The malaria
merozoite is one of the smallest known eukaryotic cells, and
so removal of the forces powering and maintaining retro-
grade ﬂow of PfSUB2 after invasion would allow subsequent
redistribution of the protease by simple diffusion in the
parasite membrane. Our observation that PfSUB2 uniformly
decorates the plasma membrane of the intracellular ring is
consistent with this.
The estimated IC50 of approximately 300 nM for inhibition
of MESH by PfSUB2PD is somewhat higher than Ki values
measured for other subtilase propeptides against their
cognate enzymes, which range from around 1–6 nM [32,33]
to around 200 nM [51]. However, the combination of a
relatively large molecular mass and the fact that it has to
interact with membrane-bound protease may preclude ready
access of PfSUB2PD to merozoite surface PfSUB2 in our
assay. Moreover, PfSUB2PD may not represent the optimal
propeptide construct; the exact internal sites at which
processing takes place during PfSUB2 maturation are
unknown, and it is well documented that even small
truncations of propeptide constructs can compromise their
inhibitory capacity (e.g., [32,33]). Despite this, PfSUB2PD
exhibited clear selectivity, showing no effect on a number of
serine proteases and only weak inhibition of a phylogeneti-
cally related bacterial subtilisin. A total of only three
subtilases are encoded in the Plasmodium genome [25].
Previously, we have conclusively excluded a role for PfSUB1
Figure 6. PfSUB2PD Inhibits MESH in a Selective, Dose-Dependent
Manner
(A) Shedding of AMA1 and MSP1 from isolated merozoites was assayed
in the presence of the indicated additives. Two different batches (1 and
2) of purified PfSUB2PD were tested, in each case alongside a similar
dilution of the membrane flow-through (Conc FT) from the final step of
concentration by ultrafiltration. Control additives used were bovine
serum albumin (BSA), purified PfSUB1PD, and EDTA. No effect on
processing was seen if PfSUB2PD was added to buffer control reactions
at the end of the incubation period (extreme right-hand lane). The lower
panel shows a titration of inhibition of MSP1 shedding in the presence of
2-fold serially decreasing concentrations of PfSUB2PD (from 1.2 lMt o
0.075 lM).
(B) Effect of propeptides on PfSUB1 activity. Progress curves showing
cleavage of substrate pepF1-6R by recombinant PfSUB1 before and
following addition of 600 nM purified PfSUB2PD or PfSUB1PD, or BSA.
Note that this concentration is in at least 300-fold molar excess over the
amount of recombinant PfSUB1 present in the assay. The time point of
addition of test proteins is arrowed.
DOI: 10.1371/journal.ppat.0010029.g006
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clusions is that the inhibition of MESH mediated by
PfSUB2PD could be the result of interactions with PfSUB3,
a subtilase that is poorly characterised but known to be
transcribed in parasite blood-stages [25]. However, we have
recently successfully disrupted the pfsub3 gene in blood-stages
of P. falciparum; the resulting parasites are viable, and
processing of both MSP1 and AMA1 occurs normally (R.
O’Donnell and M. Blackman, unpublished data), demonstrat-
ing that PfSUB3 is not essential for MESH activity.
In Toxoplasma gondii, several integral membrane microneme
adhesins that cap to the parasite posterior through inter-
actions with the actinomyosin motor are shed in the ﬁnal
seconds of invasion via cleavage within their TMD by a class
of intramembrane proteases called rhomboids [52,53]. A
malaria merozoite rhomboid-like activity has also recently
been identiﬁed [17], the role of which may be to shed
merozoite adhesins that are functional homologues of these
transmembrane adhesins [20]. The merozoite rhomboid(s)
cannot be involved in juxtamembrane shedding or shedding
of GPI-anchored proteins such as MSP1, because rhomboids
can only cleave within a TMD [54]. A Toxoplasma rhomboid,
TgROM5, was recently localised to the posterior surface of
the tachyzoite [55], suggesting that temporal and spatial
regulation of release of capped microneme proteins is
achieved through the simple expedient of maintaining the
protease at the rear of the parasite; substrates are effectively
recruited to the protease by the capping process. Our present
ﬁndings show that PfSUB2 has evolved to function in a
converse fashion; because its substrates (MSP1 and AMA1) are
uniformly distributed about the parasite circumference, the
sheddase must be tracked across the parasite surface in order
to efﬁciently engage with them. PfSUB2 probably acts in
concert with the merozoite rhomboid(s) during invasion.
Do functional homologues of PfSUB2 exist in other
Apicomplexa? Aside from the rhomboid studies alluded to
above, little is known of the molecular details of shedding of
surface and microneme proteins in other apicomplexan
genera. Two subtilisin-like serine proteases, TgSUB1 and
TgSUB2, have been identiﬁed in T. gondii tachyzoites, but
neither of these likely performs a role analogous to that of
PfSUB2; TgSUB1 is a nonessential GPI-anchored microneme
protease, whereas TgSUB2 is located in rhoptries in which it
appears to be involved in maturation of other rhoptry
proteins [56]. It remains to be seen whether Apicomplexa
other than Plasmodium use a subtilisin-like sheddase at
invasion.
Erythrocyte invasion is an obvious but thus far under-
exploited target for drugs designed to block the malarial
lifecycle. PfSUB2 may represent an excellent target for new
protease inhibitor-based drugs, and to this end, recombinant
expression of the protease in an enzymatically active form is
now a priority.
Materials and Methods
Parasite culture and transfection. P. falciparum clones D10, 3D7, and
T9/96 were maintained and free merozoites produced as described
[57]. For some experiments, medium was supplemented with
cytochalasin D or latrunculin A (Sigma-Aldrich, Poole, United
Kingdom) added from stock solutions in DMSO. To obtain highly
synchronised preparations of newly invaded ring-stage parasites,
mature schizonts isolated by centrifugation on cushions of 63%
isotonic Percoll were cultured with fresh erythrocytes for 2 h to allow
rupture and reinvasion before removal of residual schizonts as
described previously [14]. For transfection, ring-stage parasites were
electroporated with plasmid DNA using standard procedures [58].
Parasites containing integrated plasmid were selected by drug cycling
in the presence of 10 nM WR99210 (Jacobus Pharmaceuticals,
Princeton,NewJersey,UnitedStates),thenclonedbylimitingdilution.
Transfection constructs. The 3HA sequence was ampliﬁed from
pREP(HA3)42 [59] using primers HA-1 59-AGA CAC TGC TCG AGT
ACC CTT ACG ATG TT-39 and HA-2 59-GGA CAC TGG TCG ACT
CAA GCG TAA TCT GG 39 (XhoI and SalI sites are underlined, and
the incorporated translational stop codon is in bold). The product
was ligated into the unique XhoI site just upstream of the PbDT 39
UTR in pHH1-DSERA4, kindly provided by Dr. Brendan Crabb, the
Walter and Eliza Hall Institute, Melbourne, Australia, [60] to produce
construct pHH1-HA3. The 39 region of the pfsub2 gene, which
contains an internal BglII site, was ampliﬁed from T9/96 P. falciparum
genomic DNA using primers T996–1 (59-GCC CCA GGT CAT CAC
ATA TAT TCT ACT ATT CC-39), and T996–2 (59-GGA CAC TGC
TCG AGT TTC ATA AAC ATA TCA TC-39; XhoI site underlined);
primers were designed to remove the stop codon from the end of the
pfsub2 coding sequence and form a continuous reading frame into the
3HA region. The sera4 gene fragment was excised from pHH1-HA3
using BglII and XhoI and replaced with the BglII/XhoI-digested PCR
fragment to create pHH1-T996HA3. Control plasmid pHH1-T996w
was created in a similar manner but using a product ampliﬁed from
T9/96 genomic DNA with primers T9961 (59-GCC CCA GGT CAT
CAC ATA TAT TCT ACT ATT C-39) and T996w (59-CTC GAG TCA
TTT CAT AAA CAT ATC ATC AAG TTG ATT CAT TGC-39; XhoI
site underlined); this ampliﬁes a similar fragment of the 39 end of the
pfsub2 gene but including the stop codon. The sera4 gene fragment
was excised from pHH1-DSERA4 using BglII and XhoI and replaced
with the BglII/XhoI-digested pfsub2 fragment. Nucleotide sequences of
all cloned products were conﬁrmed by sequencing on both strands.
Southern blot. Parasite genomic DNA was prepared using the
DNeasy Tissue Kit (Qiagen, Valencia, California, United States) and
digested using ScaI (Roche). Digested products were electrophoresed
on a 0.7% agarose gel and transferred to Hybond N
þ Nylon
membrane (Amersham Biosciences, Buckinghamshire, United King-
dom). The blot was probed with a [
32P]-labelled, gel-puriﬁed, 569-
base pair PCR product extending from nucleotides 3,047 to 3,615 of
the T9/96 pfsub2 gene.
Indirect immunoﬂuorescence assay and ﬂuorescence microscopy.
Thin ﬁlms of P. falciparum cultures were acetone-ﬁxed and incubated
with a 1:500 dilution of the anti-HA mAb 12CA5 (mouse) or 3F10 (rat;
Roche, Basel, Switzerland) for 30 min, then with a biotinylated goat
anti-mouse or anti-rat IgG (Chemicon, Temecula, California, United
States) diluted 1:500, followed by incubation with FITC streptavidin
(Vector Laboratories, Burlingame, California, United States) diluted
1:500. For dual labelling, samples were additionally probed with mAb
4G2 (anti-PfAMA1; [10]), mAb 61.3 (anti-RhopH2; [61]), mAb H5
(anti-RAP2; I. Ling, unpublished data), or mAb 1E1 (anti-MSP119;
[62]), in each case conjugated directly to Alexa Fluor 594 (Molecular
Probes, Invitrogen, Carlsbad, California, United States), or mAb X509
(anti-MSP1; [63]) followed by incubation with Alexa Fluor 594–
conjugated anti-human IgG (Molecular Probes) diluted 1:500. Slides
were stained with DAPI (4,6-diamidino-2-phenylindole) and mounted
in Citiﬂuor (Citiﬂuor, Canterbury, United Kingdom). Images were
collected using AxioVision 3.1 software on an Axioplan 2 Imaging
system (Zeiss, Oberkochen, Germany) using a Plan-APOCHROMAT
1003/1.4 oil immersion objective, and annotated using Adobe
PhotoShop.
IEM. Samples of late schizonts were ﬁxed in 0.075% (v/v) double-
distilled glutaraldehyde and 4% (w/v) paraformaldehyde made up in
culture medium (RPMI, pH 7.2), for 20 min on ice, then washed four
times in ice-cold RPMI and dehydrated through a progressively low-
temperature ethanol series, inﬁltrated with LR White resin (EM-
SCOPE, London, United Kingdom) and polymerized by ultraviolet
light at room temperature for 48 h. For PfSUB2HA detection,
sections were immunostained with the anti-HA mAb 3F10 (diluted
1:50 or 1:100) followed by biotinylated goat anti-rat antibody (diluted
1:100) then streptavidin conjugated to 10 nm gold particles (British
Biocell International, Cardiff, United Kingdom) diluted 1:100.
Detection of PfAMA1 was carried out as described in a previous
study [64] using a rabbit polyclonal antiserum (#680) raised against
recombinant PfAMA1 (kindly donated by C. Kocken and A. Thomas,
Biomedical Primate Research Centre, Rijswijk, the Netherlands). For
control purposes, parallel samples were treated with irrelevant
primary antibodies. Sections were stained for 4 min with 2% (w/v)
aqueous uranyl acetate. Images were viewed and captured digitally
with a Hitachi 7600 electron microscope.
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synthetic gene called pfsub2synth, encoding the T9/96 PfSUB2 but
lacking the intron present in the authentic pfsub2 gene and with
codon usage optimised for expression in Trichoplusia ni insect cells,
was synthesised as described previously [65], using a total of 168 40-
mer oligonucleotides. Sequence encoding Asn22-Leu687 was ampli-
ﬁed from pfsub2synth using forward primer 59-GGT ATT GAG GGT
CGC AAC AAC AAC AAC AAC TAC TAC TTG-3’ plus reverse
primer 59-AGA GGA GAG TTA GAG CCC TAC AGG AAG CTG TAT
TTG TTG-3’ (PRO2) and cloned into the ligation-independent vector
pET-30Xa/LIC (Novagen, Madison, Wisconsin, United States). The
encoded propeptide construct was expressed in E. coli BL21-Gold
(DE3) (Stratagene, La Jolla, California, United States). Cells were
disrupted by sonication in 20 mM Tris-HCl, 300 mM NaCl, 20 mM
imidazole (pH 8.2) supplemented with protease inhibitors, and the
PfSUB2PD bound to Ni-NTA agarose (Qiagen) then eluted in the
same buffer containing 250 mM imidazole. Usually, solid urea was
then added to 8 M and the protein chromatographed on a Superdex
200 prep grade 26/60 column equilibrated in 20 mM Tris-HCl, 150
mM NaCl, 8 M urea, 1 mM DTT (pH 8.2). Polishing was performed on
a Vydac 4.63150 mm C4 RP-HPLC column eluted at 1 ml min
 1 with
a 45% 63% (v/v) gradient of acetonitrile in 0.1% (v/v) TFA over 20
min, monitoring elution at 215 nm. Eluted protein was taken up into
gel ﬁltration buffer and refolded by rapid 400-fold dilution into 20
mM Tris-HCl, 150 mM NaCl (pH 8.2). In some cases the gel ﬁltration
step was performed in the absence of urea, and the RP-HPLC step
omitted to obtain lower yields of less-pure protein that had not been
exposed to denaturing conditions. Protein was concentrated by
ultraﬁltration and the membrane ﬂow-through retained as a control
buffer for subsequent experiments. The identity of puriﬁed
PfSUB2PD was conﬁrmed by Western blot using an anti-polyhistidine
antibody (mAb HIS-1; Sigma) and mass spectrometric peptide
ﬁngerprinting of tryptic digests [15] Its concentration was calculated
from absorbance measurements at 280 nm, based on the tyrosine and
tryptophan content that predicts a molar extinction coefﬁcient of
53,305 M
 1 cm
 1 [66]. Puriﬁcation of PfSUB1 propeptide was as
described previously [33].
CD. CD spectra of PfSUB2PD were recorded from 250 to 190 nm at
20 8C in a fused silica cuvette of 1-mm path length using a Jasco J-715
spectropolarimeter. Protein concentrations were approximately 0.1
mg ml
 1 in 20 mM Tris-HCl, 150 mM NaCl (pH 8.2). Spectra
presented are averages of multiple scans recorded using a scan speed
of 200 nm min
 1 and a response time of 0.25 s. Buffer blanks were
subtracted from all spectra. Spectra were subjected to multicompo-
nent secondary structure analysis using the SELCON3 algorithm [67].
Pull-down experiments and Western blot. Percoll-enriched schiz-
onts of PfSUB2HA clone 2D were extracted into 10 volumes of 20 mM
Tris-HCl, 150 mM NaCl (pH 7.6) containing 1.5 mM sodium
deoxycholate. Clariﬁed extract (200 ll, corresponding to approx-
imately 2 3 10
8 schizonts) was mixed with up to 0.5-lg puriﬁed
PfSUB2PD or control proteins, then further supplemented with 100-
ll S-protein agarose beads (Novagen) to bind the propeptide plus any
associated proteins. Beads were washed in the above buffer then
bound proteins analysed by SDS PAGE and Western blot as described
previously [33], using mAb 3F10 to probe the blots.
Processing assays. The effect of PfSUB2PD on shedding of AMA1
and MSP1 from isolated merozoites was assayed as described [16,57].
Brieﬂy, 3D7 merozoites puriﬁed from cultures containing 10 mM
EGTA were washed, suspended in 50 mM Tris-HCl, 5 mM CaCl2 (pH
7.6) and divided into equal aliquots of approximately 4 3 10
8
merozoites, on ice. Aliquots were supplemented with puriﬁed
PfSUB2PD, puriﬁed PfSUB1 propeptide, BSA, 10 mM EDTA or
control buffers and transferred to 37 8C for 2 h. Merozoites were
pelleted, and shed AMA1 or MSP1 detected in merozoite super-
natants by Western blot using mAb 4G2 or mAb X509 respectively.
Protease assays. Production of recombinant PfSUB1 and an assay
of activity based on cleavage of the ﬂuorogenic substrate pepF1-6R
has been described previously [68]. Cleavage was monitored at room
temperature with a Cary Eclipse ﬂuorescence spectrophotometer
(Varian, Palo Alto, California, United States) equipped with a
microplate reader accessory, using excitation and emission wave-
lengths of 552 nm and 580 nm respectively. Starting concentrations
of substrate and PfSUB1 in these assays were 0.2 lM (well below the
KM for this substrate) and approximately 2 nM respectively. For other
protease assays, enzymes and substrates were obtained from Sigma.
Subtilisins BPN9 and Carlsberg were assayed using N-succinyl-L-Ala-
L-Ala-L-Pro-L-Phe-p-nitroanilide as described previously [33]. The
KM value for hydrolysis of this substrate by subtilisin BPN9 under
these conditions was 242 6 8 lM. Ki determinations were performed
as described [33]. Assays of bovine trypsin, a-chymotrypsin and
porcine pancreatic elastase were performed using published proce-
dures with substrates Na-benzoyl-DL-Arg-7-amido-4-methylcoumar-
in [69], N-succinyl-L-Ala-L-Ala-L-Pro-L-Phe-p-nitroanilide [70], and
N-succinyl-Ala-Ala-Ala-p-nitroanilide [71] respectively.
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